pentoxifylline has been researched along with Hypertrophy in 3 studies
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among the microvascular complications, diabetic nephropathy is the most frequent cause of end-stage renal disease." | 6.44 | Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes. ( Guerrero-Romero, F; Rodríguez-Morán, M, 2008) |
| "Among the microvascular complications, diabetic nephropathy is the most frequent cause of end-stage renal disease." | 2.44 | Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes. ( Guerrero-Romero, F; Rodríguez-Morán, M, 2008) |
| "Systemic arterial hypertension is a public health problem associated with an increased risk of cardiovascular disease." | 1.56 | TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure. ( Amaral, JH; Bonacio, GF; Dellalibera-Joviliano, R; Franca, SC; Garcia, VT; Mattos, BR; Rizzi, E; Tanus-Santos, JE; Vitorino, TR, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Mattos, BR | 1 |
| Bonacio, GF | 1 |
| Vitorino, TR | 1 |
| Garcia, VT | 1 |
| Amaral, JH | 1 |
| Dellalibera-Joviliano, R | 1 |
| Franca, SC | 1 |
| Tanus-Santos, JE | 1 |
| Rizzi, E | 1 |
| Dávila-Esqueda, ME | 1 |
| Vertiz-Hernández, AA | 1 |
| Martínez-Morales, F | 1 |
| Rodríguez-Morán, M | 1 |
| Guerrero-Romero, F | 1 |
1 review available for pentoxifylline and Hypertrophy
| Article | Year |
|---|---|
Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes.
Topics: Albuminuria; Animals; Diabetic Angiopathies; Diabetic Nephropathies; Disease Models, Animal; Glomeru | 2008 |
2 other studies available for pentoxifylline and Hypertrophy
| Article | Year |
|---|---|
TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Disease Models, Animal; Dose-Response Relat | 2020 |
Comparative analysis of the renoprotective effects of pentoxifylline and vitamin E on streptozotocin-induced diabetes mellitus.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hypertrophy; Kidney; | 2005 |